Sun Pharma Raises 7,816 Crore via Bonds, Below 10,000-Crore Target Amid Rising Yields
Sun Pharma raised 7,816 crore through two bond tranches with five- and seven-year maturities, pricing coupons at 8.05% and 8.20%, respectively. The company fell short of its 10,000-crore target amid rising market yields that made investors cautious. Anchor investments of 2,100 crore from insurance companies, mutual funds, and pension funds supported the fundraising. The bonds carry AAA ratings from Crisil and Icra, with the five-year tranche including a put option after 17 months.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (51/100). Lens Score 40/100.
Outlets measured: economictimes, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 22 Oct, 11:35 am. Other outlets followed.
- 1